This session will be held in the JHU SON Auditorium as part of the 2025 JHU World TB Day events at the JHU School of Nursing, 525 N. Wolfe Street. Add to Calendar.

Moderated in-person by Jonathan Golub, PhD, MPH with virtual presentations:

“Incidence and determinants of asymptomatic recurrence of tuberculosis among cured pulmonary tuberculosis patients in India.”

Mandar Paradkar, MBBS, DCH, MPH

Dr. Paradkar is trained in Pediatrics (2007-09) and Public Health (Commonwealth Scholar, 2014-15). He is currently a RICC Postdoctoral Fellow (2024-26), an early career investigator, and Operations working group chair for RePORT India Consortium. He has extensive experience (2010-ongoing) in conducting TB studies in adults and children at the BJGMC-JHU Clinical Research Site in Pune, India. Dr. Paradkar has contributed over the past decade to implementation of RePORT India studies and several pediatric clinical trials at the site including the TBM Kids (JHU), CATALYST (UNITAID), and ongoing IMPAACT (NIH, DAIDS) network trials. His publication with the CTRIUMPH-RePORT team (PLOS ONE, 2020), contributed to the Revised Indian programmatic TB Preventive Therapy Guidelines (2021).

“DOT and the Intersection of Economic and Social Vulnerabilities in TB Treatment Outcomes”

Beatriz Barreto-Duarte, MD, PhD

Dr. Duarte is a physician-scientist from Brazil. Her research focuses on investigating tuberculosis and HIV among highly vulnerable populations, with an emphasis on systems epidemiology. Her Ph.D. research at the Federal University of Rio de Janeiro utilized Brazil’s national TB database to explore the link between social vulnerability and TB treatment outcomes, identifying key strategies and populations for improving treatment success. She is currently an Assistant Professor of Medicine at ZARNS School of Medicine, a postdoctoral fellow with the Regional Prospective Observational Research for Tuberculosis (RePORT) International, and a collaborating researcher at the Fundação Oswaldo Cruz (Fiocruz) in Bahia.

“Anti-TB drug exposure among patients with diabetes and pre-diabetes in Brazil”

Felipe Ridolfi, MD, PhD

Felipe Ridolfi, MD, MSc, PhD, is an Infectious Diseases (ID) Specialist and a Postdoctoral Research Fellow at the TB Center within the Division of Infectious Diseases in the Department of Medicine at Vanderbilt University Medical Center (VUMC). His current postdoctoral research focuses primarily on tuberculosis (TB) drug concentrations in persons with diabetes. He is also investigating the progression of TB among contacts across international sites of the Regional Prospective Observational Research in Tuberculosis (RePORT), as well as TB case representativeness and treatment outcomes of the TB Sentinel Research Network (TB-SRN). Dr. Ridolfi completed his MD and ID training in Brazil and has extensive experience in TB, TB/HIV, and multidrug-resistant tuberculosis (MDR-TB) management. He obtained his MSc and PhD in Clinical Research in Infectious Diseases from the National Institute of Infectious Disease Evandro Chagas, Fiocruz, in Rio de Janeiro, Brazil. His PhD research explored factors influencing TB treatment outcomes, adverse drug reactions, and genetic variants that affect antiretroviral metabolism.

  Joining virtually? Register for the Zoom link here.

JHU TRAC World TB Day Agenda

11am – 12pm ET – The RePORT International Coordinating Center/ Early Stage Investigators Session

12 – 1pm ET – 16th Annual George W. Comstock Lecture: “Ending TB Can’t be Business as Usual”
Neil Martinson, MBBCh, MPH
Adjunct Associate Professor, Medicine
Executive Director, Perinatal HIV Research Unit, Soweto, South Africa

1:15pm ET – Livestream & Lunch: UCSF Inter-TRAC World TB Day ESI Collaboration- Next Generation of Researchers Tackling TB
Speakers include JHU TRAC Postdoctoral Awardee Manish Gupta, PhD